| Target Price | $45.90 |
| Price | $42.35 |
| Potential |
8.38%
register free of charge
|
| Number of Estimates | 21 |
|
21 Analysts have issued a price target Exelixis, Inc. 2026 .
The average Exelixis, Inc. target price is $45.90.
This is
8.38%
register free of charge
$63.00
48.76%
register free of charge
$30.30
28.45%
register free of charge
|
|
| A rating was issued by 26 analysts: 17 Analysts recommend Exelixis, Inc. to buy, 9 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Exelixis, Inc. stock has an average upside potential 2026 of
8.38%
register free of charge
|
| Jan '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Billion $ | 2.17 | 2.66 |
| 22.79% | ||
| EBITDA Margin | 33.14% | 34.11% |
| 2.92% | ||
| Net Margin | 24.04% | 29.22% |
| 21.57% |
22 Analysts have issued a sales forecast Exelixis, Inc. 2026 . The average Exelixis, Inc. sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Exelixis, Inc. EBITDA forecast 2026. The average Exelixis, Inc. EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
22 Exelixis, Inc. Analysts have issued a net profit forecast 2026. The average Exelixis, Inc. net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Jan '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 1.76 | 2.90 |
| 64.77% | ||
| P/E | 14.59 | |
| EV/Sales | 3.89 |
22 Analysts have issued a Exelixis, Inc. forecast for earnings per share. The average Exelixis, Inc. EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| UBS |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Barclays |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Nov 05 2025 |
| Guggenheim |
Locked
➜
Locked
|
Locked | Nov 03 2025 |
| RBC Capital |
Locked
➜
Locked
|
Locked | Oct 21 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
UBS:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Barclays:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Nov 05 2025 |
|
Locked
Guggenheim:
Locked
➜
Locked
|
Nov 03 2025 |
|
Locked
RBC Capital:
Locked
➜
Locked
|
Oct 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


